Regeneron Pharmaceuticals, Inc.
Non-human animals having a humanized B-cell activating factor gene

Last updated:

Abstract:

Non-human animals, cells, methods and compositions for making and using the same are provided, wherein the non-human animals and cells comprise a humanized B-cell activating factor gene. Non-human animals and cells that express a human or humanized B-cell activating factor protein from an endogenous B-cell activating factor locus are described.

Status:
Grant
Type:

Utility

Filling date:

8 Jan 2019

Issue date:

11 May 2021